Feminizing adrenocortical carcinoma with distant metastases: can surgery be considered?

  • Alessandro Fancellu | afancel@uniss.it Unit of General Surgery 2, Department of Clinical and Experimental Medicine, University of Sassari, Italy.
  • Antonio Pinna Unit of General Surgery 2, Department of Clinical and Experimental Medicine, University of Sassari, Italy.
  • Alberto Porcu Unit of General Surgery 2, Department of Clinical and Experimental Medicine, University of Sassari, Italy.

Abstract

Functioning adrenocortical carcinomas are rare diseases with dismal prognosis. A 41-year-old man presenting with gynecomastia had a giant feminizing adrenocortical carcinoma at stage IV. Although surgical resection was controversial, we removed the primary tumor to reduce the mass effects. He lived for 12 months with an acceptable quality of life. Gynecomastia may be the first sign of feminizing adrenal malignancies. Surgery may ameliorate the quality of life in selected patients with metastatic disease.

Google Scholar

Google Scholar

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Author Biographies

Alessandro Fancellu, Unit of General Surgery 2, Department of Clinical and Experimental Medicine, University of Sassari
MD, PhD
Antonio Pinna, Unit of General Surgery 2, Department of Clinical and Experimental Medicine, University of Sassari
MD
Alberto Porcu, Unit of General Surgery 2, Department of Clinical and Experimental Medicine, University of Sassari
MD
Published
2014-07-09
Info
Issue
Section
Case Reports
Keywords:
adrenocortical carcinoma, feminizing, treatment, gynecomastia, rare tumor.
Statistics
  • Abstract views: 1047

  • PDF: 478
  • HTML: 679
How to Cite
Fancellu, A., Pinna, A., & Porcu, A. (2014). Feminizing adrenocortical carcinoma with distant metastases: can surgery be considered?. Clinics and Practice, 4(2). https://doi.org/10.4081/cp.2014.651